Cabazitaxel Viatris 60 mg/3 ml

Cabazitaxel Viatris 60 mg/3 ml is a medicine authorised by Swissmedic under authorisation number 69122. The authorisation holder is Viatris Pharma GmbH. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 30 March 2023 and the authorisation is limited until 29 March 2028. ATC code L01CD04 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 69122
  • ATC L01CD04
  • Synthetic medicines
Authorisation data
Authorisation number69122
NameCabazitaxel Viatris 60 mg/3 ml
Full nameCabazitaxel Viatris 60 mg/3 ml, Konzentrat zur Herstellung einer Infusionslösung
Authorisation holderViatris Pharma GmbH
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01CD04
First authorisation30 March 2023
Authorisation validity29 March 2028
Strengths
No.NameDispensing categoryAuthorisation date
1Cabazitaxel Viatris 60 mg/3 ml, Konzentrat zur Herstellung einer InfusionslösungA30 March 2023

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)L01CD0407.16.1.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Cabazitaxel Viatris 60 mg/3 ml authorised in Switzerland?

Yes. Cabazitaxel Viatris 60 mg/3 ml is authorised by Swissmedic under authorisation number 69122, data as of 01 September 2026. The authorisation is limited until 29 March 2028.

Which dispensing category does Cabazitaxel Viatris 60 mg/3 ml have?

Cabazitaxel Viatris 60 mg/3 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Cabazitaxel Viatris 60 mg/3 ml?

The authorisation holder is Viatris Pharma GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com